Upgrade to SI Premium - Free Trial

Fate Therapeutics (FATE) PT Lowered to $8 at Jefferies

March 6, 2025 5:19 AM
Jefferies analyst Michael Yee lowered the price target on Fate Therapeutics (NASDAQ: FATE) to $8.00 (from $10.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles